Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes
Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the...
Trending menu:
-
![]()
Nerlynx (neratinib) for the Treatment of Breast Cancer
-
![]()
Olumiant (baricitinib) for the Treatment of Moderate-to-Severe Rheumatoid Arthritis
-
![]()
Cabometyx (cabozantinib) for Treatment of Patients with Advanced Renal Cell Carcinoma
-
![]()
Keytruda (pembrolizumab) for the Treatment of Metastatic Melanoma
-
![]()
Tremfya (guselkumab) for the Treatment of Plaque Psoriasis
-
![]()
Kymriah (tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukaemia
Most Read
- FDA accelerated review denial is a blow to Spectrum’s poziotinib
- New drugs and therapeutic options help the immune system fight cancer
- Roche’s Tecentriq threatens BMS’ Opdivo in small cell lung cancer market
- The challenges of using stem cells in neurology
- Another BACE inhibitor fails in phase III trials
Company A-Z
Latest Content
Evidera and CSS partner on patient-centric research development
Evidera has reached an exclusive collaboration agreement with Shin Nippon Biomedical Laboratories’ (SNBL) subsidiary Clinical Study Support (CSS) to jointly deliver more consulting and analytical capabilities for clinical research.
VirTrial and ACRP partner on hybrid decentralised clinical trials
Technology company VirTrial has partnered with the Association of Clinical Research Professionals (ACRP) to provide a training and certificate programme to all domestic and abroad members of ACRP.
Medable to enhance digital real-world evidence research network
US-based data-driven clinical trials provider Medable is set to join the American Heart Association’s Center for Health Technology & Innovation Innovators Network to improve a patient-centric digital system that connects patients and researchers.
Signant Health launches partner programme to improve clinical trials
Signant Health has launched a new partner programme to collaborate with clinical research organisations (CROs) in a bid to improve clinical trials with patient-centric technology.
Two monoclonal antibodies show promise in PALM Ebola trial
Preliminary findings from the Pamoja Tulinde Maisha (PALM) clinical trial have revealed that two monoclonal antibodies, REGN-EB3 and mAb114, produced a higher chance of survival in Ebola patients.
Onconova, Mission Bio partner to advance oncology trials using single-cell genomics
Onconova Therapeutics has formed a strategic collaboration to use Mission Bio’s Tapestri platform for targeted single-cell DNA analysis in order to study its novel cancer therapy, rigosertib, through clinical trials.
Campbell University, Durham Tech partner on clinical research transfer
Campbell University and Durham Technical Community College have established the US state of North Carolina’s first transfer opportunity programme (TOP) in clinical research.
New respiratory syncytial virus vaccine shows promise in Phase I trial
An experimental vaccine developed by the National Institute of Allergy and Infectious Diseases (NIAID) to protect against respiratory syncytial virus (RSV) has yielded positive data in a Phase I clinical trial.
Tryon Medical, Javara partner on clinical trials offering
Javara and Tryon Medical Partners have collaborated to offer industry-sponsored, outpatient clinical trials to the latter’s patients.
AAV gene therapy shows positive results in Batten disease trial
Amicus Therapeutics has announced interim data from a Phase I/II clinical trial of an AAV gene therapy for the treatment of CLN6 Batten disease in children.
Latest News
Close
Close
Close
Go Top
